Urine‐Stable Aptamer‐Conjugated Gold Nanorods for the Early Detection of High‐Grade Bladder Cancer Residual Disease
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202403314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Chiara Venegoni und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Oncology/Unit of Urology, URI, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Gold, Aptamers, Nucleotide, Nanotubes. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, HORIZON EUROPE European Innovation Council.
Abstract (Originalsprache)
The limitations of current diagnostic imaging techniques and therapies for bladder cancer are associated with and responsible for the recurrence and progression of residual disease, with an impact on social costs and quality of life of patients. This study delivers a cost‐effective solution for the detection of bladder cancer residual disease, which is represented by the early detection of bladder cancer lesions < 1 mm. Urine‐stable 34‐mer SH‐terminated 2′F‐Py‐RNA aptamer that recognizes the integrin α5β1, expressed by 81% of human high‐grade non‐muscle invasive bladder cancer, is developed. The intravesical instillation of aptamer‐conjugated gold nanorods as contrast agent for photoacoustic imaging is validated in a preclinical model of orthotopic bladder cancer expressing the integrin α5β1. The photoacoustic signal of gold nanorods remains on the tumor surface for 3 h and allows early detection of cancer lesions < 1 mm. The aptamer is internalized into lysosomes, an opportunity that paves the way for lysosomal‐mediated drug release in tumor cells. This study highlights the potential of urine‐stable aptamer for the delivery of a solution to target the residual high‐grade bladder cancer disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Experimental Oncology/Unit of Urology, URI, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.
- Department of Industrial Chemistry "Toso Montanari", University of Bologna, Via P. Gobetti 85, Bologna, 40129, Italy.
- Institute of Experimental Endocrinology and Oncology "Gaetano Salvatore", National Research Council, Naples, 80131, Italy.
- Università Vita-Salute San Raffaele, Milan, 20132, Italy.
- FUJIFILM Visualsonics Inc., Amsterdam, 1114 AB, The Netherlands.
ORCID-Profile: Chiara Venegoni, Silvia Tortorella, Alessandra Caliendo, Irene Locatelli, Alessia Di Coste, Erica Locatelli, Filippo Capancioni, Emanuela Bua, Simona Camorani, Andrea Salonia, Francesco Montorsi, Jithin Jose, Marco Moschini, Laura Cerchia, Mauro Comes Franchini, Massimo Alfano
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- HORIZON EUROPE European Innovation Council
Zitieren
APA
Venegoni, C., Tortorella, S., Caliendo, A., Locatelli, I., Coste, A. D., Locatelli, E., Capancioni, F., Bua, E., Camorani, S., Salonia, A., Montorsi, F., Jose, J., Moschini, M., Cerchia, L., Franchini, M. C., & Alfano, M. (2025). Urine‐Stable Aptamer‐Conjugated Gold Nanorods for the Early Detection of High‐Grade Bladder Cancer Residual Disease. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403314
Vancouver
Venegoni C, Tortorella S, Caliendo A, Locatelli I, Coste AD, Locatelli E, et al. Urine‐Stable Aptamer‐Conjugated Gold Nanorods for the Early Detection of High‐Grade Bladder Cancer Residual Disease. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403314
BibTeX
@article{Venegoni2025,
author = {Venegoni, Chiara and Tortorella, Silvia and Caliendo, Alessandra and Locatelli, Irene and Coste, Alessia Di and Locatelli, Erica and Capancioni, Filippo and Bua, Emanuela and Camorani, Simona and Salonia, Andrea and Montorsi, Francesco and Jose, Jithin and Moschini, Marco and Cerchia, Laura and Franchini, Mauro Comes and Alfano, Massimo},
title = {Urine‐Stable Aptamer‐Conjugated Gold Nanorods for the Early Detection of High‐Grade Bladder Cancer Residual Disease},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202403314}
}
EUVIMED